Antibiotic

Oxanosine is an antibiotic derived from the Streptomyces MG265-CF34 strain, exhibiting notable anti-tumor properties. This compound functions as a substrate for adenosine deaminase, highlighting its potential utility in various research applications related to microbial activity and cancer treatment. Its unique biochemical interactions make it a valuable reagent for studies in antibiotic development and tumor biology.

5-Hydroxy-4-oxo-L-norvaline is an antifungal antibiotic that inhibits protein biosynthesis in microbial cells. Its mechanism of action makes it a valuable tool in studying fungal growth and resistance. This compound is particularly useful for research applications focused on understanding antifungal mechanisms and the development of new therapeutic strategies against fungal infections.

Fluvirucin B2 is an antibiotic that specifically targets the influenza A virus. It exhibits antiviral activity by inhibiting viral replication, making it a valuable tool in researching antiviral therapeutic strategies. Fluvirucin B2 can be utilized in studies focused on understanding influenza pathogenesis and the development of effective antiviral agents.

Reumycin is a 7-azapteridine antibiotic that functions as an antitumor agent. It exhibits cytotoxic activity against various tumor cell lines, including Airy carcinoma, sarcoma-180, sarcoma-37, and lymphosarcoma. This compound is primarily utilized in cancer research to study its effects on tumor proliferation and cell viability.

Pluracidomycin C2 is a carbapenem antibiotic that targets bacterial cell wall synthesis. It exhibits significant activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool for studying antibiotic resistance and microbial pathogenicity. Its unique mechanism of action and broad-spectrum efficacy render it useful for various research applications in microbiology and pharmacology.

Monamycin H2 is an ester peptide antibiotic that targets bacterial protein synthesis. It exhibits potent activity against Gram-positive bacteria, making it valuable in microbiological research. This compound is utilized to study antibiotic resistance and the mechanisms of bacterial growth inhibition.

Laidlomycin phenylcarbamate functions as a semisynthetic polyether antibiotic that exhibits notable antiparasitic activity. Its mechanism involves inhibiting protein synthesis, making it valuable for research into antimicrobial resistance and therapies involving parasitic infections. This compound is relevant in the study of antibiotic efficacy and the development of new treatments in infectious disease research.

Paldimycin B is a semi-synthetic antibiotic that exerts its activity primarily against Staphylococcus aureus and coagulase-negative staphylococci. It demonstrates significant antibacterial properties, making it valuable for research focused on bacterial infections and antibiotic resistance mechanisms. This compound serves as a useful tool for studying the efficacy and resistance profiles of various bacterial strains in the context of antimicrobial therapy.

Desacetylcephalothin sodium is a metabolite of the antibiotic Cephalothin, primarily targeting bacterial cell wall synthesis. Although it exhibits relatively weak antimicrobial activity compared to its parent compound, it serves as a valuable tool for studying antibiotic metabolism and resistance mechanisms. This reagent is useful in research applications related to the assessment of beta-lactam antibiotics and their derivatives.

BMS-180680 is a broad-spectrum antibiotic targeting gram-negative bacteria. It demonstrates potent antibacterial activity against Pseudomonas aeruginosa with a minimum inhibitory concentration (MIC) of 0.25 µg/ml. Additionally, BMS-180680 is resistant to hydrolysis by various β-lactamases, including TEM-2 and PSE enzymes, making it a valuable tool for research in antibiotic resistance and drug development.

Pneumocandin A4 is a lipopeptide antibiotic that targets the synthesis of 1,3-β-glucan, crucial for fungal cell wall integrity. It exhibits significant antifungal activity against Candida species, demonstrating an IC50 range of 0.07-0.5 μg/mL in vitro. This compound is valuable for research applications focused on antifungal mechanisms and the development of new therapeutic agents against fungal infections.

Arisostatin B is a tetrocarcin class antibiotic primarily targeting Gram-positive bacteria. It exhibits significant antibacterial properties, making it effective in combatting infections caused by resistant strains. Additionally, Arisostatin B demonstrates antitumor activity, supporting its potential applications in cancer research and therapy development.

Anti-MRSA agent 12 is an antibiotic that demonstrates significant antibacterial activity against Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli, with minimum inhibitory concentrations (MIC) of 7.81 μM for both Staphylococcus species and 62.5 μM for E. coli. This compound specifically targets methicillin-resistant Staphylococcus aureus (MRSA) by effectively inhibiting biofilm formation. It is a valuable reagent for research in antibiotic resistance and biofilm-related infections.

Azidocillin sodium is a semi-synthetic β-lactam antibiotic that exhibits activity against bacterial infections. Characterized by its azide functionality, it retains antibacterial efficacy and can be employed in studies of osteitis associated with dental surgery, otitis media, and enterococcal septicemia. Additionally, Azidocillin sodium serves as a versatile click chemistry reagent, participating in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules. This dual functionality enhances its utility in both microbiological research and chemical biology applications.

Ala0-Actagardine is a lantibiotic that targets bacterial cell membranes, derived from the cultures of Actinoplanes liguriae ATCC 31048. This compound exhibits potent antibacterial activity against a range of Gram-positive pathogens, making it valuable for research in antibiotic resistance and pathogen sensitivity studies. Its unique mechanism of action provides insights into peptide antibiotics and their potential therapeutic applications in infectious disease treatment.

Lankacidinol A is an antibiotic that demonstrates significant antibacterial activity against Gram-positive bacteria. This compound is utilized in research to investigate its efficacy in combating bacterial infections and may provide insights into novel antibiotic development. Its mechanism of action contributes to the growing understanding of antimicrobial resistance and the potential for new therapeutic strategies.

Nothramicin is an anthracycline antibiotic that primarily targets mycobacterial strains. It exhibits potent anti-mycobacterial activity, making it a valuable reagent for research focused on tuberculosis and other mycobacterial infections. This compound is essential for studies investigating the mechanisms of antibiotic resistance and the development of novel therapeutic strategies.

Arylomycin A3 is a lipohexapeptide antibiotic targeting Gram-positive bacteria. This compound exhibits potent antibacterial activity, making it valuable for research on antibiotic resistance and the development of new antimicrobial agents. Its mechanism involves inhibition of bacterial protein synthesis, offering insights into bacterial growth regulation and antibiotic pathways.

Lenapenem hydrochloride hydrate, a potent carbapenem antibiotic, exerts strong antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. This compound is utilized in research to elucidate mechanisms of bacterial resistance and to evaluate its therapeutic potential in treating severe bacterial infections. Its effectiveness against difficult-to-treat pathogens makes it a valuable tool in microbiological studies and antibiotic development.

Demycarosyl platenomycin primarily targets bacterial ribosomes as an antibiotic. It exhibits selective activity against Gram-positive bacteria, making it a useful tool for research in antibacterial mechanisms and the study of bacterial resistance. Its unique structure allows for exploration of antibiotic efficacy and resistance pathways, providing insights into the development of new therapeutic agents.

Epoxyquinomicin C is an antibiotic derived from the soil bacterium Amycolatopsis sp. It displays anti-inflammatory properties, particularly in models of collagen-induced arthritis, making it a valuable tool for studying inflammatory pathways. Additionally, Epoxyquinomicin C serves as a synthetic precursor for the NF-κB inhibitor DHMEQ, facilitating research into therapeutic applications targeting NF-κB signaling.

Pneumocandin B2 is a lipopeptide antibiotic that targets fungal cell wall synthesis by inhibiting 1,3-β-D-glucan. It demonstrates potent anti-Candida activity, with an inhibitory concentration (IC50) ranging from 0.07 to 0.5 μg/mL in vitro. This compound is primarily utilized in research focused on antifungal mechanisms and development of novel treatments for fungal infections.

13-Deoxycarminomycin is an antibiotic that primarily targets bacterial cells, exhibiting significant antibacterial activity. In addition to its antibiotic properties, this compound demonstrates cytotoxic effects against tumor cell lines such as HeLa and P388. It holds potential for applications in cancer research, particularly in exploring its anti-tumor mechanisms and therapeutic efficacy.

Cedarmycin B is an antibiotic that exhibits potent activity against fungal pathogens, specifically Candida species, Cryptococcus neoformans, and Aspergillus fumigatus. The minimum inhibitory concentration (MIC) values range from 12.5 to 50 μg/mL, indicating its effectiveness in inhibiting fungal growth. This compound is useful for research applications focused on antifungal drug development and resistance studies.

Aureonuclemycin is a nucleoside antibiotic derived from Staphylococcus aureus, featuring two distinct forms: Type A and Type B. Aureonuclemycin A shares structural similarities with certain herbicides and contains an adenine moiety, while Aureonuclemycin B comprises 5′-deoxyadenosine and demonstrates significant antibacterial activity. This compound is valuable in research focused on bacterial diseases, including bacterial leaf blight in rice, citrus canker, and bacterial leaf spot in rice, making it a crucial tool for studying plant-pathogen interactions and developing targeted antibacterial strategies.

Mycinamicin V is an ester peptide antibiotic that targets bacterial protein synthesis. It exhibits significant antibacterial activity against Gram-positive bacteria, making it a valuable compound for research in microbiology and infectious disease studies. Mycinamicin V is utilized in the investigation of bacterial resistance mechanisms and the development of new antimicrobial therapies.

LBM-415 is a peptide deformylase (PDF) inhibitor with demonstrated antibacterial activity against antimicrobial-resistant gram-positive cocci. It exhibits a minimum inhibitory concentration (MIC90) range of 0.12-8 µg/ml, indicating its potency in inhibiting bacterial growth. Additionally, the inhibition of efflux pump activity may enhance the sensitivity of bacteria to LBM-415, thereby improving its overall antibacterial efficacy. This compound serves as a valuable tool for research into antibiotic resistance and the development of novel therapeutic strategies.

Napyradiomycin A2 is an antibiotic that targets Gram-positive bacteria and exhibits significant mycobacterial activity. Its mechanism of action involves the interference with bacterial cell wall synthesis, making it a valuable tool in the study of antibiotic resistance and the development of novel therapeutic agents. This compound is suited for research applications in microbiology and drug discovery, particularly in the context of mycobacterial infections such as tuberculosis.

Sakyomicin B is a benzoquinone antibiotic that targets Gram-positive bacteria and mycobacteria. Isolated from the strain of Nocardia sp. M-53, it exhibits potent antimicrobial properties, making it valuable for research into bacterial infections and antibiotic resistance. Its unique mechanism and efficacy in combating specific bacterial strains highlight its significance in the field of microbiology and pharmacology.

Bicyclomycin is an antibiotic that targets bacterial RNA polymerase, inhibiting bacterial transcription. It exhibits selective antibacterial activity against Gram-negative bacteria, including Escherichia coli and Klebsiella species, without cross-resistance. Bicyclomycin is valuable for research focusing on infectious diseases and the mechanisms of antibiotic resistance.

Arugomycin is an anthracycline antibiotic primarily targeting Gram-positive bacteria. Its mechanism of action involves intercalation into DNA, which also suggests potential as an antitumor agent. This compound is valuable for research in antibiotic resistance and cancer therapeutics.

Fluvirucin B3 is an antibiotic that targets the influenza A virus. It has demonstrated significant antiviral activity, making it a valuable compound for research focused on influenza infections. Its application in laboratory studies provides insights into the mechanisms of viral resistance and aids in the development of novel therapeutic strategies against influenza A virus.

Epoxyquinomicin D is a potent antibiotic derived from Amycolatopsis sp., primarily targeting bacterial pathogens. It demonstrates notable anti-inflammatory properties, particularly in models of collagen-induced arthritis. This compound is valuable in research focused on antibiotic efficacy and the modulation of inflammatory processes in autoimmune conditions.

1,5-Dideoxy-1,5-imino-D-mannitol is an antibiotic that exhibits antibacterial properties through its action on bacterial cell wall synthesis. This compound is valuable for research aimed at understanding bacterial resistance mechanisms and the development of new antibacterial agents. Its specific activity against various bacterial strains makes it an important tool in antimicrobial studies.

Cefoxazole is a β-lactam antibiotic that contains an isoxazole moiety, primarily targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity against a range of Gram-positive and Gram-negative organisms. Cefoxazole is applicable in research related to the treatment and study of infectious diseases, particularly in evaluating its efficacy against resistant strains.

Emerin is an antibiotic derived from the fungal strain Aspergillus nidulans. It exhibits potent antibacterial activity, primarily targeting bacterial ribosomes to inhibit protein synthesis. Emerin has valuable applications in microbiological research and the study of bacterial resistance mechanisms.

Actinobolin is an antibiotic that primarily inhibits protein synthesis by targeting both bacterial and eukaryotic ribosomes. Demonstrating effective antibacterial activity, Actinobolin exhibits IC50 values of 19.2 μmol/L against Mycobacterium smegmatis, 27.9 μmol/L against Escherichia coli, and 288 μmol/L against rabbit reticulocyte lysate (RRL). This compound is valuable for research applications focused on protein synthesis inhibition and antimicrobial activity studies.

Chrymutasin B is a glycosidic antibiotic with potent cytotoxic properties. Its primary mechanism involves inhibiting cellular proliferation, making it a valuable tool for antitumor research. Chrymutasin B is utilized in studies focused on cancer therapeutics and the exploration of antibiotic efficacy against cancer cell lines.

Minimycin, also known as Oxazinomycin, is an antitumor antibiotic targeting a variety of cancer cell lines. It exhibits broad-spectrum antibacterial activity and has demonstrated significant inhibitory effects against mouse Ehrlich ascites carcinoma, as well as both ascitic and solid forms of sarcoma-180. This compound is particularly valuable for research in oncology and antimicrobial studies.

2'-Amino-2'-deoxyadenosine is a nucleoside antibiotic known for its ability to inhibit various strains of Mycoplasma. By targeting the synthesis pathways within these microorganisms, it demonstrates significant antibacterial activity. This compound is widely employed in research applications focused on studying bacterial infections and developing novel therapeutic strategies against Mycoplasma-related diseases.

Noboritomycins B is a polyether antibiotic that exerts potent activity against Gram-positive bacteria. It demonstrates effectiveness in inhibiting bacterial growth, making it valuable for studies focused on bacterial infections. Additionally, Noboritomycins B exhibits a weak anti-coccidial effect, providing insights into its potential applications in parasitic research.

Pneumocandin A2 is a lipopeptide antibiotic that primarily targets the synthesis of 1,3-β-glucan, an essential component of fungal cell walls. This compound exhibits potent anti-Candida activity with an IC50 value ranging from 0.07 to 0.5 µg/mL in vitro, making it a valuable tool for studying fungal infections. Pneumocandin A2 is utilized in research focused on antifungal mechanisms and the development of therapeutic interventions against Candida species.

Everninomicin D is a potent antibiotic targeting Gram-positive bacteria. It exhibits significant antibacterial activity, making it a valuable tool for research involving bacterial infections and the study of antibiotic resistance mechanisms. Its unique mechanism of action allows for exploration in the development of new antimicrobial therapies.

Neomycin F is an aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as mycobacteria and certain protozoa. Neomycin F is particularly effective in treating infections such as amebic dysentery and select cases of bacillary dysentery, making it a valuable reagent in microbiological research and pharmaceutical applications.

N(5)-Hydroxy-L-arginine is an antibiotic that exerts its activity against both Gram-positive and Gram-negative bacteria. This compound is valuable for research focused on bacterial inhibition and exploring mechanisms of antibiotic resistance. Its unique structure and function make it an essential reagent for investigating antibacterial therapeutic strategies.

DC-86-M is an antibiotic derived from the bacterium Streptomyces luteogriseus, known for its potent antibacterial properties. It demonstrates antibacterial activity against various strains, including Bacillus subtilis, Staphylococcus aureus, Enterococcus faecalis, Vibrio anguillarum, and Proteus vulgaris, with a minimum inhibitory concentration (MIC) of less than 1 μg/mL. Additionally, DC-86-M has shown antitumor effects against mouse sarcoma 180, exhibiting a lethal dose (LD50) of 25 mg/kg. This reagent can be utilized in studies involving antibiotic efficacy and cancer research.

Monamycin G1 is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits significant antibacterial activity, making it a valuable tool for microbiological research. This compound can be utilized in studies involving bacterial resistance mechanisms and the development of new therapeutic agents against Gram-positive infections.

Sesquicillin A is an insecticidal antibiotic that serves as a fungal metabolite derived from white plantain. It is effective in inhibiting the growth of Artemia salina brine shrimp, demonstrating a minimal inhibitory concentration (MIC) of 6.25 µg/mL. This compound is valuable for research applications focused on entomology and the development of biopesticides.

Pluracidomycin D is a carbapenem antibiotic that targets a broad range of bacterial pathogens. It exhibits significant antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool in microbiological research and antibiotic development. Its unique mechanism of action contributes to its effectiveness in combating bacterial resistance, paving the way for potential therapeutic applications.

Gentamicin A is an antibiotic that targets a broad spectrum of Gram-positive and Gram-negative bacteria. It exhibits significant antibacterial activity, particularly against methicillin-sensitive Staphylococcus species. This compound is widely utilized in microbiological research to study bacterial resistance mechanisms and to evaluate antibiotic efficacy in clinical and laboratory settings.